Working… Menu

Early Mobilization After Total Knee Arthroplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01604382
Recruitment Status : Completed
First Posted : May 23, 2012
Last Update Posted : May 23, 2012
Information provided by (Responsible Party):
Andreas Harsten, Region Skane

Brief Summary:
Patients undergoing elective total knee arthroplasty are randomized to either intrathecal anesthesia, wound infiltration with local anesthetics and standardized postoperative care (NA = neuraxial anesthesia) or general anesthesia, intraoperative glucocorticoids with accelerated postoperative care principles (GA). The study hypothesis is that GA would reduce length-of-hospital stay. Outcome variables are postoperative nausea and vomiting, mobilization rate, pain, requirement of analgesics, and length-of-hospital stay.

Condition or disease Intervention/treatment Phase
Osteoarthritis Drug: General Anesthesia Drug: Neuraxial anesthesia Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Randomized Study of Whether General or Regional Anesthesia for Patients Undergoing Elective Total Knee Arthroplasty Could Effect Length of Hospital Stay
Study Start Date : September 2008
Actual Primary Completion Date : May 2009
Actual Study Completion Date : June 2010

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: treatment
Receives General Anesthesia as described above
Drug: General Anesthesia
General Anesthesia as described above
Other Names:
  • Propofol
  • Remifentanil

Placebo Comparator: Placebo
Patients receives neuraxial anesthesia as described above
Drug: Neuraxial anesthesia
Neuraxial anesthesia as described above
Other Name: Bupivacaine

Primary Outcome Measures :
  1. Length of hospital stay [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 3 days"). ]
    Length of hospital stay is defined as teh time from end of surgery until the patient is ready to be discharged

Secondary Outcome Measures :
  1. Post operative pain [ Time Frame: measured the first 48 hrs after surgery ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   40 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with osteoarthritis scheduled for TKA at the department of orthopedic surgery, Hässleholm Hospital, Sweden, are eligible for participation in the study.

Exclusion Criteria:

  • body mass index (BMI) > 35 m/kg2,
  • prior major knee surgery to the ipsilateral knee,
  • ongoing infection, known immunological deficiency or ASA physical status category > IV.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01604382

Layout table for location information
Lund University, Hässleholm Hospital
Hässleholm, Skane, Sweden, 381 25
Sponsors and Collaborators
Region Skane
Layout table for investigator information
Study Director: Mads Werner, M.D. PhD Multidisciplinary Pain Center, Copenhagen, Denmark
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Andreas Harsten, Head of dept Anesthesiol, M.D., Region Skane Identifier: NCT01604382    
Other Study ID Numbers: HLM-2012-CPH
First Posted: May 23, 2012    Key Record Dates
Last Update Posted: May 23, 2012
Last Verified: May 2012
Keywords provided by Andreas Harsten, Region Skane:
Total Knee Arthroplasty (TKA)
Additional relevant MeSH terms:
Layout table for MeSH terms
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Hypnotics and Sedatives
Anesthetics, Intravenous
Anesthetics, General
Analgesics, Opioid